The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000415303
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
2/03/2026
Date registered
Help: Date registered
2/04/2026
Date last updated
Help: Date last updated
2/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
2/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Activ8Wait: Using an app get speech therapy treatment started while you’re on the waiting list
Scientific title
Activ8Wait: Evaluating the efficacy of speech therapy with a parent-supervised app-based intervention for children with speech sound disorder who are on waiting lists
Additional trial identifiers [1] 316672 0
None
Universal Trial Number (UTN)
U1111-1336-5073
Trial acronym
Activ8Wait
Related trial records

Health condition
Health condition(s) studied:
Speech Sound Disorder 340915 0
Condition category
Condition code
Physical Medicine / Rehabilitation 337067 337067 0 0
Speech therapy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Parent-supervised app-based intervention program (Say Bananas) that delivers speech pathology treatment to children with speech sound disorder (SSD), in the home, while they are waiting for standard pathology services. The intervention applies Principles of Motor Learning embedded in a Mario-style video platformer game to provide 20-min high-intensity daily practice sessions, while capping children to 1 session per day to control screen time.
Children play the game for 20 mins/day (this elicits 100 speech responses), 4 times a week for 4 weeks (total of 1600 speech productions). Speech targets elicited in the game are tailored to each child's specific speech errors. Parents are given one 1-hour session to setup up the app with their child's speech targets and train them in judging when their child's responses are correct or incorrect, so that they can enter the judgments in to the game after each child response during home practice with the app.
The delivery of the intervention via an app negates the need for measuring fidelity. However, adherence to the dosage is tracked via app metadata. Also, all responses in the app are uploaded to a secure server so that reliability of the parent's judgments of their child's response accuracy can be compared against clinicians. Inter-rater reliability will be reported as well as correlation between parent reliability and magnitude of child's response to treatment.
Intervention code [1] 333352 0
Treatment: Other
Intervention code [2] 333354 0
Behaviour
Description of the comparator or control
Standard care: no formal speech pathology intervention.
Control group
Active

Outcomes
Primary outcome [1] 344584 0
Percent accuracy for treated speech sounds
Timepoint [1] 344584 0
Baseline (children randomised to receive 3-4 tests over 1-2 weeks) Experimental probes (weekly tests, completed at the end of each treatment week) Maintenance probe (test at 1-month post-treatment)
Primary outcome [2] 344842 0
Percent accuracy for speech sounds that are untreated but related to the treated speech sounds
Timepoint [2] 344842 0
Baseline (children randomised to receive 3-4 tests over 1-2 weeks) Experimental probes (weekly tests, completed at the end of each treatment week) Maintenance probe (test at 1-month post-treatment)
Secondary outcome [1] 458475 0
Percent phonemes correct on the Speech Test for Australian Children (STAC, Baker et al., 2019) test from pre-post treatment
Timepoint [1] 458475 0
Once at Baseline, once within one week of completing the treatment program
Secondary outcome [2] 458477 0
Dosage achieved (number of speech responses recorded over 4 weeks)
Timepoint [2] 458477 0
Data will be extracted immediately after the final treatment session has been completed.
Secondary outcome [3] 458479 0
User (child and parent) experience and satisfaction with the treatment delivery model. This will be assessed as a composite outcome.
Timepoint [3] 458479 0
Within 1 week after the final treatment session has been completed
Secondary outcome [4] 458480 0
Parent ratings of app quality
Timepoint [4] 458480 0
Within 1 week after the final treatment session has been completed
Secondary outcome [5] 458485 0
Amount of hand and face movement when producing speech.
Timepoint [5] 458485 0
Baseline (children randomised to receive 3-4 tests over 1-2 weeks) Experimental probes (weekly tests, completed at the end of each treatment week) Maintenance probe (test at 1-month post-treatment)
Secondary outcome [6] 458486 0
Reliability of parent judgments of child's speech accuracy during treatment
Timepoint [6] 458486 0
Data are taken from each at-home treatment session using the app.

Eligibility
Key inclusion criteria
Children aged 4–12 years; born in Australia and English speaking; no/mild receptive language difficulty, pass a hearing screening using the Ling Seven Sound Check (Ling, 1976).
Minimum age
4 Years
Maximum age
12 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Children who do not speak English, have moderate or worse receptive language skills, upper limb physical disability that prevents them from effectively using the hand controls in videogames, parent report of uncorrected hearing impairment, are currently enrolled in community-based speech therapy for a speech sound disorder.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The first (and subsequent odd-numbered) child recruited per age bracket (4:0-4:11 years, 5:0-5:11 years, etc) will be randomly assigned to the treatment/waitlist group using concealed envelopes. The second (and subsequent even-numbered) child at that age bracket will be assigned to the other group. This enables matching across groups by age, which is a powerful variable in speech sound development that needs to be controlled.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Sample size estimates
We will recruit up to 40 children (20 treated immediately, 20 assigned to waiting list/standard care). Very few studies exist that compare SSD treatment to standard care/no treatment. McLeod et al. (2020) reported a very large effect size of d = 4.7 for their study with 36 treated children and 30 in the waiting list condition (Cohen's d = (-4.72 - 7.4) / 2.5728 = 4.71 (Treated vs Advice waiting list)). For a more conservative effect size of 1, alpha .05, power 0.8, one-tailed, with allocation ratio of 1, G*Power 3.1 estimates a sample size of 14 per group (17 for two-tailed). We propose 20 per group to account for possible attrition.

Primary Hypothesis: Is treatment superior to waiting list condition
i) Mixed model ANOVA with between subjects factor of group (immediate treatment vs waitlist) and within subjects factor of time (pre vs post-treatment). Dependent measure - speech accuracy. Possible covariates: SSD severity, age.
ii) Nonparametric test (Mann Whitney) will compare change scores (post-pre) across groups on survey rating scales; text box responses will be evaluated qualitatively with thematic analysis (Braun & Clarke, 2021).
Secondary Hypotheses:
iii) Pearson/Spearman Correlation analysis to determine whether actual dosage is associated with magnitude of improvement for treated words in the treated group.
iv) Kappa correlation coefficient and Ppos/Pneg calculations to determine agreement between parent and clinician scoring of children’s speech at each timepoint (binary), including agreement on correct (Ppos) vs incorrect (Pneg) productions.
v) Cross-correlation and Inter-Trial Coherence/Phase Locking to examine the synchrony between onsets of speech syllables and videoed facial/hand movement events.


Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29209 0
University of Sydney - Camperdown
Recruitment postcode(s) [1] 45518 0
2006 - Camperdown

Funding & Sponsors
Funding source category [1] 321284 0
University
Name [1] 321284 0
The University of Sydney
Country [1] 321284 0
Australia
Funding source category [2] 321460 0
Commercial sector/Industry
Name [2] 321460 0
Say66 Pty Ltd
Country [2] 321460 0
Australia
Funding source category [3] 321461 0
Commercial sector/Industry
Name [3] 321461 0
Kinephonics Trading Pty Ltd
Country [3] 321461 0
Australia
Primary sponsor type
University
Name
University of Sydney
Address
Country
Australia
Secondary sponsor category [1] 324005 0
None
Name [1] 324005 0
Address [1] 324005 0
Country [1] 324005 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319813 0
The University of Sydney Human Research Ethics Committee
Ethics committee address [1] 319813 0
Ethics committee country [1] 319813 0
Australia
Date submitted for ethics approval [1] 319813 0
17/12/2025
Approval date [1] 319813 0
19/12/2025
Ethics approval number [1] 319813 0
2025/HE000713

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148490 0
Prof Kirrie Ballard
Address 148490 0
Speech Pathology, Faculty of Medicine and Health, Susan Wakil Health Building, University of Sydney, Camperdown NSW 2006
Country 148490 0
Australia
Phone 148490 0
+61 431416936
Fax 148490 0
Email 148490 0
Contact person for public queries
Name 148491 0
Kirrie Ballard
Address 148491 0
Speech Pathology, Faculty of Medicine and Health, Susan Wakil Health Building, University of Sydney, Camperdown NSW 2006
Country 148491 0
Australia
Phone 148491 0
+61 431416936
Fax 148491 0
Email 148491 0
Contact person for scientific queries
Name 148492 0
Kirrie Ballard
Address 148492 0
Speech Pathology, Faculty of Medicine and Health, Susan Wakil Health Building, University of Sydney, Camperdown NSW 2006
Country 148492 0
Australia
Phone 148492 0
+61 431416936
Fax 148492 0
Email 148492 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
What individual participant data might be shared?
• De-identified individual participant data:
• Published results
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
• Health economic analyses
• Studies testing whether findings can be repeated or confirmed
• Teaching research methods or developing new statistical techniques
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
Yes: Video and audio recordings cannot be shared as they contain re-identifiable data collected from children.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.